Profile data is unavailable for this security.
About the company
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
- Revenue in HKD (TTM)11.70bn
- Net income in HKD2.08bn
- Incorporated1995
- Employees12.44k
- LocationGrand Pharmaceutical Group LtdUnits 3302The Center, 99 Queen's Road Central Hong KongHKG
- Phone+852 28663718
- Fax+852 28662521
- Websitehttps://www.grandpharma.cn/
More ▼
Mergers & acquisitions
| Acquired company | 512:HKG since announced | Transaction value |
|---|---|---|
| Nanjing Kainite Medical Technology Co Ltd | 59.28% | 15.08m |
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Ltd | 3.45bn | -1.62bn | 17.59bn | 1.87k | -- | 2.90 | -- | 5.10 | -1.52 | -1.52 | 3.21 | 5.37 | 0.4119 | 3.19 | 6.53 | -- | -19.29 | -33.80 | -27.61 | -39.12 | 61.52 | 64.07 | -46.83 | -186.77 | 2.68 | -- | 0.2108 | -- | 49.59 | 98.38 | 23.17 | -- | 32.19 | -- |
| Vigonvita Life Sciences Co Ltd | -100.00bn | -100.00bn | 18.44bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -94.07 | -- | -1,848.73 | -- | -- | -- |
| Ab&B Bio Tech Co Ltd JS | 366.68m | -254.18m | 20.26bn | 583.00 | -- | 531.53 | -- | 55.26 | -0.646 | -0.646 | 0.932 | 0.0969 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.29bn | 1.78k | 5.56 | 2.11 | 5.41 | 4.31 | 4.18 | 4.18 | 5.39 | 11.02 | 0.3966 | 7.09 | 3.86 | 2,598,991.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Shanghai Henlius Biotech Inc | 6.57bn | 933.59m | 24.35bn | 3.54k | 40.95 | 9.91 | 17.24 | 3.71 | 1.72 | 1.72 | 12.08 | 7.10 | 0.5386 | 1.73 | 5.86 | 1,868,170.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.97bn | 3.47bn | 24.60bn | 17.40k | 6.53 | 1.29 | 5.90 | 1.54 | 1.91 | 1.91 | 8.79 | 9.70 | 0.5397 | 2.89 | 5.97 | 939,504.00 | 11.71 | 9.37 | 17.46 | 14.54 | 47.24 | 44.33 | 21.70 | 15.06 | 1.60 | -- | 0.2472 | 26.01 | 0.1387 | 10.39 | -1.54 | 32.89 | 37.25 | 45.96 |
| PegBio Co Ltd | -100.00bn | -100.00bn | 24.66bn | 58.00 | -- | 84.18 | -- | -- | -- | -- | -- | 0.749 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.07 | -- | 0.2439 | -- | -- | -- | -1.49 | -- | -- | -- |
| Sunshine Lake Pharma Co Ltd | 3.82bn | -448.45m | 24.99bn | 6.53k | -- | 56.46 | 20,892.96 | 6.54 | -0.7777 | -0.7777 | 6.63 | 0.7683 | -- | -- | -- | 583,523.60 | -- | -- | -- | -- | 73.62 | -- | -12.86 | -- | 0.7739 | -0.7591 | 0.5111 | -- | -37.06 | -- | -212.17 | -- | -- | -- |
| Grand Pharmaceutical Group Ltd | 11.70bn | 2.08bn | 26.83bn | 12.44k | 12.72 | 1.54 | 10.35 | 2.29 | 0.5943 | 0.5943 | 3.35 | 4.90 | 0.4557 | 3.66 | 3.88 | 976,472.80 | 7.99 | 10.40 | 10.81 | 14.24 | 57.64 | 61.04 | 17.53 | 22.80 | 0.9872 | -- | 0.2107 | 29.12 | 10.59 | 12.06 | 31.30 | 16.49 | 0.7398 | 22.05 |
| China Resources Pharmaceutical Group Ltd | 295.54bn | 3.20bn | 28.96bn | 86.00k | 9.06 | 0.5118 | 2.22 | 0.098 | 0.509 | 0.509 | 47.04 | 9.01 | 0.9434 | 5.57 | 2.41 | 4,065,209.00 | 2.86 | 3.14 | 10.28 | 11.78 | 15.81 | 15.59 | 3.03 | 3.02 | 1.12 | 11.26 | 0.4248 | 22.38 | 5.30 | 7.41 | -13.06 | 2.95 | 12.42 | 7.30 |
| Duality Biotherapeutics Inc | 2.46bn | -3.21bn | 30.29bn | 191.00 | -- | 8.97 | -- | 12.32 | -36.99 | -36.99 | 28.71 | 37.47 | -- | -- | -- | 14,459,600.00 | -- | -- | -- | -- | 37.13 | -- | -130.43 | -- | -- | -- | 0.0228 | -- | 8.66 | -- | -193.82 | -- | -- | -- |
| Xuanzhu Biopharmaceutical Co Ltd | 36.19m | -630.13m | 32.73bn | 197.00 | -- | 34.17 | -- | 904.41 | -1.22 | -1.22 | 0.0699 | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | 41.02 | -- | -1,740.97 | -- | 1.10 | -- | 0.0013 | -- | 103,672.40 | -- | -85.13 | -- | -- | -- |
| Simcere Pharmaceutical Group Ltd | 8.05bn | 996.87m | 33.46bn | 6.82k | 31.81 | 3.89 | 23.97 | 4.16 | 0.4053 | 0.4053 | 3.26 | 3.31 | 0.5845 | 2.20 | 2.81 | 1,222,488.00 | 7.24 | 8.74 | 9.93 | 12.42 | 81.00 | 78.53 | 12.39 | 15.60 | 1.57 | 4.72 | 0.1453 | 44.12 | 0.4148 | 5.67 | 2.57 | -6.09 | 8.48 | -- |
Data as of Feb 16 2026. Currency figures normalised to Grand Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
5.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 41.40m | 1.17% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 30.63m | 0.86% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 27.01m | 0.76% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2025 | 19.85m | 0.56% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 17.01m | 0.48% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 15.80m | 0.45% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 12.55m | 0.35% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 8.92m | 0.25% |
| Purekind Fund Management Co., Ltd.as of 30 Jun 2025 | 8.55m | 0.24% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 8.03m | 0.23% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
